Fresenius Medical Care AG & Co KGaA ADR buy Societe Generale
Start price
17.11.23
/
50%
€17.70
Target price
17.11.24
-
Performance (%)
15.25%
End price
18.11.24
€20.40
Summary
This prediction ended on 18.11.24 with a price of €20.40. The BUY prediction by Societe_Generale finished with a performance of 15.25%. Dividends of €0.58 are taken into consideration when calculating the performance. Societe_Generale has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fresenius Medical Care AG & Co KGaA ADR | -0.980% | -0.980% | -4.717% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% |
Comments by Societe_Generale for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ADR diskutieren
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) was upgraded by analysts at Societe Generale from a "hold" rating to a "buy" rating.
Ratings data for FMS provided by MarketBeat
In the thread Trading Fresenius Medical Care AG & Co KGaA ADR
Die von Societe_Generale gewählte maximale Laufzeit wurde überschritten